Chemical pharma research reports
Sector: Pharma & biotech · 1 reports
Subscribe →- Chemical pharma Chemical pharma Pharma & biotech Fuxiang shares 300497 fundamental data research analysis report.
China’s key macro indicators for total social financing (TSF) and credit show that the outstanding TSF increased by 7.20% year-on-year this period, down 18.18% from the same period last year, and down 2.70% month-on-month. China’s key macro liquidity indicator, DR007, stood at 1.42% this period, down 1.00% year-on-year and up 0.37% month-on-month. This period, the Shanghai Composite Index closed at 3,891.60 points, showing a downward trend. This period, the Shenzhen Component Index closed at 13,454.74 points, showing a downward trend. The current price of Fuxiang shares is 22.05 yuan, the trend of weekly K-line MA10 in the medium and long term is rising, and the current structure of weekly K-line is rising. Recently, the 10-day moving average (MA10) of the daily price chart is trending upward, and the current daily candlestick pattern is also bullish. Trading volume has increased, and market activity has picked up.
2026/9/17